Tryptamine Therapeutics Limited

ASX:TYP Stock Report

Market Cap: AU$60.0m

Tryptamine Therapeutics Limited Company Information

Tryptamine Therapeutics Limited's employee growth, exchange listings and data sources

Key Information

  • Name: Tryptamine Therapeutics Limited
  • Ticker: TYP
  • Exchange: ASX
  • Founded: 2019
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: AU$59.992m
  • Shares Outstanding: 1.28b
  • Website: https://www.tryptherapeutics.com

Location

  • Tryptamine Therapeutics Limited
  • 697 Burke Road
  • Suite 201
  • Camberwell
  • Victoria
  • 3124
  • Australia

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
TYPASX (Australian Securities Exchange)YesNew Common SharesAUAUDOct 2023
TYPT.FOTCPK (Pink Sheets LLC)YesNew Common SharesUSUSDOct 2023
TYPCHIA (Chi-X Australia)YesNew Common SharesAUAUDOct 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/21 13:15
End of Day Share Price 2024/11/21 00:00
Earnings2024/06/30
Annual Earnings2024/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.